Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 493
Immune Disorders Drugs 208
Drug Discovery 170
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 101
Pharmaceuticals 98
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 50
Brain Cancer Drugs 49
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Bladder Cancer Drugs 26
Analgesics 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

2,535 Results (Page 1 of 127)
- Relevance
  Sort by

Methotrexate Drugs - Global Strategic Business Report

 Report
July 2025
564 Pages
Global

From

€5131EUR$5,850USD£4,404GBP

Paclitaxel Injection Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3938EUR$4,490USD£3,380GBP

Triamcinolone - Global Strategic Business Report

 Report
July 2025
378 Pages
Global

From

€5131EUR$5,850USD£4,404GBP

Paclitaxel Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
95 Pages
Global

From

€3500EUR$4,275USD£3,109GBP

Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030

 Report
January 2020
473 Pages
Global

From

€4297EUR$4,899USD£3,688GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Adalimumab, Infliximab and Etanercept Biosimilars Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3938EUR$4,490USD£3,380GBP

Triamcinolone Ointment Chlorofluorocarbons Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
115 Pages
Global

From

€4166EUR$4,750USD£3,576GBP

Sunitinib Malate - Global Strategic Business Report

 Report
July 2025
193 Pages
Global

From

€5131EUR$5,850USD£4,404GBP

Ampicillin Trihydrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
80 Pages
Global

From

€3500EUR$4,275USD£3,109GBP

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

 Report
March 2020
306 Pages
Global

From

€4297EUR$4,899USD£3,688GBP

Etopophos Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
August 2024
84 Pages
Global

From

€3500EUR$4,275USD£3,109GBP

Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

 Report
October 2023
75 Pages
Global

From

€5219EUR$5,950USD£4,479GBP

Human Immunodeficiency Virus Therapeutics Market by Drug Class, Regimen Type, Therapy Line, Mode of Administration, Patient Type, Distribution Channel - Global Forecast to 2030

 Report
May 2025
190 Pages
Global

From

€3109EUR$3,545USD£2,669GBP

€3455EUR$3,939USD£2,965GBP

Drug Delivery Across Blood Brain Barriers - Global Strategic Business Report

 Report
July 2025
297 Pages
Global

From

€5131EUR$5,850USD£4,404GBP

Renal Cell Carcinoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1754EUR$2,000USD£1,506GBP

Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) Drug Overview 2019

 Drug Pipelines
September 2019
118 Pages
Global

€8771EUR$10,000USD£7,528GBP

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
83 Pages
Global

From

€3070EUR$3,500USD£2,635GBP

Advanced Renal Cell Carcinoma (RCC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€6973EUR$7,950USD£5,984GBP

Aztreonam Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

 Report
January 2025
89 Pages
Global

From

€3500EUR$4,275USD£3,109GBP

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2024-2032

 Report
August 2024
136 Pages
Global

From

€2630EUR$2,999USD£2,257GBP

2,535 Results (Page 1 of 127)
- 1
- 2
- 3

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.